Peter Hammarsten

Contact

Works at

Affiliated as physician at Department of Medical Biosciences Section: Pathology

By 6M, vån 2, Sjukhusområdet Umeå universitet, 901 85 Umeå

Publications Publications

Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome

The Prostate, John Wiley & Sons 2019, Vol. 79, (5) : 435-445

Adamo, Hanibal Hani; Hammarsten, Peter; Hägglöf, Christina; et al.

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

Modern Pathology, Vol. 32, (9) : 1310-1319

Hammarsten, Peter; Josefsson, Andreas; Thysell, Elin; et al.

High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting

PLOS ONE, Vol. 11, (10)

Hammarsten, Peter; Scherdin, Tove Dahl; Hagglöf, Christina; et al.

High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting

PLOS ONE, Public library science 2015, Vol. 10, (10)

Nilsson, Maria; Hägglöf, Christina; Hammarsten, Peter; et al.

Morphological and morphometric characterization of direct transdifferentiation of support cells into hair cells in ototoxin-exposed neonatal utricular explants

Hearing Research, Vol. 321 : 1-11

Werner, Mimmi; Van De Water, Thomas R.; Hammarsten, Peter; et al.

Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15

Cancer Research, American Association for Cancer Research 2014, Vol. 74, (13) : 3408-3417

Bruzzese, Francesca; Hägglöf, Christina; Leone, Alessandra; et al.

ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome

PLOS ONE, Public Library Science 2014, Vol. 9, (9)

Hammarsten, Peter; Winther, Johanna; Rudolfsson, Stina H; et al.

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers

PLOS ONE, Vol. 9, (2) : e86824-

Hägglöf, Christina; Hammarsten, Peter; Strömvall, Kerstin; et al.

Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: A Bayesian network analysis of data from a tissue microarray

The Prostate, Vol. 74, (11) : 1107-1117

Häggström, Jenny; Cipriano, Mariateresa; Plym Forshell, Linus; et al.

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome

European Journal of Cancer, Vol. 50, (10) : 1829-1835

Tidehag, Viktor; Hammarsten, Peter; Egevad, Lars; et al.

Association between cannabinoid CB1 receptor expression and Akt signalling in prostate cancer

PLOS ONE, Vol. 8, (6) : e65798-

Cipriano, Mariateresa; Häggström, Jenny; Hammarsten, Peter; et al.

Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1831, (10) : 1579-1587

Fowler, Christopher J.; Josefsson, Andreas; Thors, Lina; et al.

Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression

PLOS ONE, Vol. 7, (10) : e47994-

Hammarsten, Peter; Cipriano, Mariateresa; Josefsson, Andreas; et al.

Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer

Expert Opinion in Medical Diagnostics, Informa Healthcare 2011, Vol. 5, (1) : 37-47

Halin Bergström, Sofia; Hammarsten, Peter; Adamo, Hani; et al.

Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome

American Journal of Pathology, Vol. 179, (4) : 1961-1968

Josefsson, Andreas; Adamo, Hani; Hammarsten, Peter; et al.

LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer.

International Journal of Cancer, Wiley 2011, Vol. 128, (12) : 2843-2852

Thomasson, Marcus; Wang, Baofeng; Hammarsten, Peter; et al.

Tumour cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer

PLOS ONE, Vol. 5, (12) : e15205-

Fowler, Christopher J; Hammarsten, Peter; Bergh, Anders

Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.

Clinical Cancer Research, Vol. 16, (4) : 1245-1255

Hammarsten, Peter; Karalija, Amar; Josefsson, Andreas; et al.

Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival

PLOS ONE, Vol. 5, (5) : e10747-

Hägglöf, Christina; Hammarsten, Peter; Josefsson, Andreas; et al.

Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy

American Journal of Pathology, Vol. 177, (2) : 1031-1041

Johansson, Anna; Rudolfsson, Stina; Hammarsten, Peter; et al.

Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4

PLOS ONE, Public Library of Science 2010, Vol. 5, (8) : e12275-

Thors, Lina; Bergh, Anders; Persson, Emma; et al.

A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer

European Journal of Cancer, Vol. 45, (1) : 174-182

Chung, Sui Chu; Hammarsten, Peter; Josefsson, Andreas; et al.

Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment.

The Prostate, Vol. 67, (4) : 370-7

Halin, Sofia; Hammarsten, Peter; Wikström, Pernilla; et al.

Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats.

Prostate, Vol. 67, (6) : 573-581

Hammarsten, Peter; Rudolfsson, Stina; Henriksson, Roger; et al.

Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition.

Clinical Cancer Research, Vol. 12, (24) : 7431-7436

Hammarsten, Peter; Halin, Sofia; Wikström, Pernilla; et al.

Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated mice.

Prostate, Vol. 58, (1) : 57-65

Lissbrant, Ingela Franck; Hammarsten, Peter; Lissbrant, Erik; et al.

Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome

Adamo, Hanibal; Hammarsten, Peter; Hägglöf, Christina; et al.

View publications in DiVA